Loading
New surgical tools, imaging probes and radiotherapy hardware invented in universities rarely attract investors. A dedicated fund would pay for prototyping, safety testing and first-in-human studies.
A fund for academic devices and techniques in cancer surgery and radiotherapy: intraoperative imaging probes, margin-assessment tools, low-cost brachytherapy applicators, FLASH-capable beam systems, adaptive planning software, robotic instruments. It pays for design-for-manufacture, ISO 13485 quality systems, biocompatibility and safety testing and IDEAL-framework early studies. Device venture capital is thin outside cardiology and orthopaedics, and academic engineering groups have no path to first-in-human without it. The fund would work with translational institutes and the surgical and radiotherapy trials networks proposed elsewhere in this wave.
Shares Optical & fluorescence imaging, Fluorescence-guided surgery, Surgery and radiotherapy cure most, get least.
Shares FLASH radiotherapy, Brachytherapy.
Shares Mandatory staged registries for new surgical techniques before wide adoption, Fluorescence-guided surgery, Surgery and radiotherapy cure most, get least.
Shares Mandatory staged registries for new surgical techniques before wide adoption, A permanently funded international network for randomised cancer surgery trials, Surgery and radiotherapy cure most, get least.
Shares Translational research: crossing the valley of death, The valley of death between lab and product.
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.
Shares Mandatory staged registries for new surgical techniques before wide adoption, A permanently funded international network for randomised cancer surgery trials, Surgery and radiotherapy cure most, get least.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/